Literature DB >> 23791161

Coronary revascularization in diabetic patients: off-pump versus on-pump surgery.

André Renner1, Armin Zittermann, Anas Aboud, Thomas Pühler, Kavous Hakim-Meibodi, Wulf Quester, Diethelm Tschoepe, Jochen Börgermann, Jan F Gummert.   

Abstract

BACKGROUND: Coronary artery bypass grafting (CABG) is a well-established procedure for treating diabetic patients with multivessel disease, but extracorporeal circulation and cardioplegia-induced cardiac arrest introduce a severe burden to these patients. The present study investigated if off-pump CABG decreases 30-day mortality and mid-term mortality in diabetic patients in comparison with conventional CABG.
METHODS: From February 2009 through October 2011, data from 355 consecutive adult diabetic patients undergoing off-pump CABG and 502 patients undergoing on-pump CABG were prospectively recorded. Data analysis was performed by propensity score (PS)-adjusted logistic regression analysis and PS-adjusted Cox regression analysis. The primary endpoint was 30-day mortality. Secondary endpoints were major complications and mortality on follow-up.
RESULTS: Off-pump CABG was associated with a significantly lower 30-day mortality rate (0.3% vs 4.2%; adjusted odds ratio [OR] = 0.09 [95% confidence interval (CI):0.01 to 0.70] p = 0.021) than on-pump CABG. Results coincided with a lower rate of postoperative neurologic complications in patients undergoing off-pump CABG (1.7% vs 5.4%; adjusted OR = 0.31 [95% CI: 0.12 to 0.77] p = 0.012) and a less frequent need for hemofiltration in these patients (3.4% vs 10.4%; adjusted OR = 0.30 [95% CI: 0.14 to 0.64] p = 0.002). The off-pump technique decreased the 6-month mortality rate (2.3% vs 8.8%; adjusted hazard ratio = 0.27 [95% CI: 0.12 to 0.61] p = 0.002) and also the 1-year mortality rate (4.0% vs 10.6%; adjusted hazard ratio = 0.40 [95% CI: 0.22 to 0.75] p = 0.004) significantly.
CONCLUSIONS: Our data indicate that in terms of postoperative complications and early and mid-term survival, off-pump CABG is superior to the on-pump technique in diabetic patients.
Copyright © 2013 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  23; ACT; ANCOVA; BMI; CABG; DM; ECC; EF; GFR; IABP; ICU; LOS; MVD; OR; PS; aPTT; activated clotting times; activated partial thromboplastin time; analysis of covariance; body mass index; coronary artery bypass grafting; diabetes mellitus; ejection fraction; extracorporeal circulation; glomerular filtration rate; intensive care unit; intraaortic balloon pump; low output syndrome; multi-vessel disease; odds ratio; propensity score

Mesh:

Year:  2013        PMID: 23791161     DOI: 10.1016/j.athoracsur.2013.04.063

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  The current status of multi-arterial off-pump coronary artery bypass grafting.

Authors:  Suzuki Tomoaki; Asai Tohru
Journal:  Surg Today       Date:  2015-02-13       Impact factor: 2.549

2.  On-pump versus off-pump coronary artery bypass graft surgery among patients with type 2 diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.

Authors:  Ashima Singh; Hartzell V Schaff; Maria Mori Brooks; Mark A Hlatky; Stephen R Wisniewski; Robert L Frye; Edward Y Sako
Journal:  Eur J Cardiothorac Surg       Date:  2015-05-11       Impact factor: 4.191

Review 3.  On-pump versus off-pump coronary artery bypass graft surgery: what do the evidence show?

Authors:  Alfredo José Rodrigues; Paulo Roberto Barbosa Evora; Paulo Victor Alves Tubino
Journal:  Rev Bras Cir Cardiovasc       Date:  2013 Oct-Dec

Review 4.  Can the onset of heart failure be delayed by treating diabetic cardiomyopathy?

Authors:  Anna Marcinkiewicz; Stanisław Ostrowski; Józef Drzewoski
Journal:  Diabetol Metab Syndr       Date:  2017-04-04       Impact factor: 3.320

5.  Myocardial protection and early outcome of different coronary surgical techniques for diabetic patients with triple vessels.

Authors:  Yu Lei; Tianxiang Gu; Enyi Shi; Chun Wang; Fang Qin
Journal:  Ann Saudi Med       Date:  2014 Sep-Oct       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.